Eric Venker - President & Immunovant CEO at Roivant Sciences Ltd.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & Immunovant CEO
Stock Symbol
ROIV on Nasdaq
All Insider Reports
All Insider Reports

Eric Venker - trading volume in the past year for Roivant Sciences Ltd.

Holdings reported by Eric Venker for Roivant Sciences Ltd.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 6.08M $123M $20.22 Nov 7, 2025 Direct Common Stock
Common Shares 1.5M $30.4M $20.27 Nov 20, 2025 Direct

Transactions reported by Eric Venker for Roivant Sciences Ltd.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.